Fate Therapeutics' founder to get patent for stem cell method

02/4/2010 | Bloomberg

Fate Therapeutics said Rudolf Jaenisch, one of the firm's founders and a Massachusetts Institute of Technology scientist, will secure a U.S. patent for a technique that can transform cells derived from mammals into stem cells. Fate has an exclusive license to the stem cell method, which also is claimed by two other researchers.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC